Chase AIPricingFAQs
Display currency
Loading news…

ReSync Bio

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
San Francisco, California, United States Founded 2024 1-10 employees For Profit

ReSync Bio is a scientific software firm that develops solutions to help biopharmaceutical companies.

ReSync Bio was acquired by Benchling in 2025.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
26
IT spend
$521K

Company Info

Founded
2024
Employees
1-10
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
2
HQ
San Francisco, California, United States
Region
San Francisco Bay Area, West Coast, Western US
Exit date
Aug 20, 2025

Signals & Scores

Heat score
Low
Trend (7d)
-0.1
Trend (30d)
-0.1
Trend (90d)
-0.3

Key People at ReSync Bio

Founder & CEO

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to ReSync Bio

Loading news…

FAQs about ReSync Bio

People who checked this page also checked these

Browse the full Acquirezy directory.
ReSync Bio - Company Profile, Full Acquisitions List, Funding and Investments